LIMK1 and colorectal carcinoma: Our data show that PHB positioned in the front end of the plasma membrane not only acts as a positive regulator of the ROCK/LIMK pathway by altering the expression of p-cofilin in CRC cells, but also weakens the depolymerization of F-actin and extends the F-actin to the leading-edge.